RCT | Sutimlimab in patients with cold agglutinin disease without recent transfusion.

Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial – Blood

Editorial: A virtuosic CADENZA played by sutimlimab – Blood

Commentary: Sutimlimab Shows Efficacy in Patients With CAD Without Recent Transfusion – AJMC

Commentary on Twitter

Read #openaccess article ‘Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial’ recently published in @BloodJournalhttps://t.co/K13e9V1c0K @ASH_Hematology pic.twitter.com/61oqWewcJ2

— Elsevier Hematology (@ELShematology) September 12, 2022